PERSPECTA

News from every angle

Results for "Pharmaceutical sector"

122 stories found

Switzerland and China Reach Deal to Abolish Most Tariffs
Businessswissinfo10d ago

Switzerland and China Reach Deal to Abolish Most Tariffs

Switzerland and China have finalized an agreement to eliminate nearly all tariffs on Swiss exports to China. This deal is expected to significantly boost trade between the two nations, following a rebound in Swiss exports driven by the pharmaceutical sector.

PCN Seals 505 Illegal Drug Stores in Cross River State
WorldPremium Timespunch-ngvanguard-ng1mo ago3 sources

PCN Seals 505 Illegal Drug Stores in Cross River State

The Pharmacists Council of Nigeria (PCN) has sealed 505 illegal medicine outlets in Cross River State. This action is part of an ongoing effort to regulate and sanitize the pharmaceutical sector.

Emerging Industries Reshape US Election Funding Landscape
Technologyvijesti-me1d ago

Emerging Industries Reshape US Election Funding Landscape

Cryptocurrency firms, artificial intelligence companies, and sports betting operators are rapidly becoming major political donors, challenging the long-standing dominance of Wall Street, energy, and pharmaceutical sectors in American campaign finance.

Huawei Expands AI Partnerships Into China’s Pharmaceutical Sector
Technologychannel-news-asiaseeking-alphastar-malaysia4d ago3 sources

Huawei Expands AI Partnerships Into China’s Pharmaceutical Sector

Huawei is planning to deepen its artificial intelligence collaborations within China’s pharmaceutical industry, according to company executives. The initiative aims to leverage AI technologies to accelerate drug development and enhance healthcare research capabilities.

Clawback on Hospital Medicines Reaches 80.7%, Threatening Innovation
Businessiefimeridanewsbeast2mo ago2 sources

Clawback on Hospital Medicines Reaches 80.7%, Threatening Innovation

The clawback on hospital medicines in Greece has reached a new negative record of 80.7%, raising concerns among pharmaceutical associations. This high clawback rate is seen as a significant threat to innovation in the pharmaceutical sector and patient access to new treatments.

Patent Expiry Drives Biopharma M&A Activity
Businesscapital-bg2mo ago

Patent Expiry Drives Biopharma M&A Activity

The biopharmaceutical sector is experiencing a clear recovery in mergers and acquisitions, largely driven by an impending wave of patent expirations and a gradual improvement in the investment climate.

GLP-1 Developer Kailera Raises $625M in Record-Breaking IPO
BusinessYahooseeking-alpha4mo ago2 sources

GLP-1 Developer Kailera Raises $625M in Record-Breaking IPO

GLP-1 developer Kailera has made history by raising $625 million in a record-breaking initial public offering, with shares priced at $16 each. This significant IPO marks a major milestone for the company in the pharmaceutical sector.

Quantum Technology in the Pharmaceutical Sector
Technologyla-vanguardia6mo ago

Quantum Technology in the Pharmaceutical Sector

Quantum technology offers new opportunities in the pharmaceutical sector, from improving research and development to optimizing production and personalized medicine, strengthening a strategic sector in Spain.

Fidson Leads Nigeria's Pharmaceutical Sector in Q1 2026
BusinessPremium Times1mo ago

Fidson Leads Nigeria's Pharmaceutical Sector in Q1 2026

Fidson has emerged as a dominant player in Nigeria's pharmaceutical sector during the first quarter of 2026. This growth is attributed to factors such as population increase, urbanization pressures, and heightened healthcare awareness.

Investment Strategies for the Evolving GLP-1 Drug Market
Healthseeking-alpha2mo ago

Investment Strategies for the Evolving GLP-1 Drug Market

The article explores how investors can position themselves to capitalize on the ongoing innovation and increasing competition within the GLP-1 drug market. It discusses future trends and investment opportunities in the pharmaceutical sector.

Analysts Evaluate Top LNG and Medical Stocks for 2026
BusinessYahoo3mo ago

Analysts Evaluate Top LNG and Medical Stocks for 2026

Analysts are evaluating BP and Cheniere Energy (LNG) as potential top LNG stocks to buy in 2026, while also considering Pfizer Inc. (PFE) among the best medical stocks for investment according to billionaires. These assessments provide insights into future investment opportunities in the energy and pharmaceutical sectors.